Past, Present and Future Directions of gpt delta Rodent Gene Mutation Assays

Takehiko Nohmi1

  • 1Biological Safety Research Center, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.

Insights

New genotoxicity assays in transgenic rodents, like the gpt delta system, improve in vivo chemical safety testing. These methods detect gene mutations and DNA damage, crucial for regulating environmental and food chemicals.

Area of Science:

  • Toxicology
  • Genetics
  • Environmental Health

Background:

  • Genotoxicity is a key factor in chemical regulation due to potential health risks, even at low doses.
  • Genotoxic carcinogens require stricter regulation than non-genotoxic ones.
  • The Ames test is a standard for genotoxicity but requires in vivo validation.

Purpose of the Study:

  • To introduce and explain the gpt delta gene mutation assays for in vivo genotoxicity evaluation.
  • To highlight the application of these assays in food safety research.
  • To discuss the future of in vivo genotoxicity testing.

Main Methods:

  • Development of gpt delta transgenic mouse and rat models for whole-body genotoxicity assessment.
  • Utilizing gpt and Spi- assays to detect point mutations and deletions, respectively.
  • The Spi- assay's capability to analyze DNA deletions and rearrangements from double-strand breaks.

Main Results:

  • The gpt delta system provides a comprehensive method for evaluating genotoxicity in vivo.
  • These assays allow for the detection of various genetic alterations, including point mutations and deletions.
  • The Spi- assay offers unique insights into DNA damage responses.

Conclusions:

  • Gpt delta gene mutation assays are valuable tools for assessing chemical genotoxicity in vivo.
  • These assays enhance the evaluation of food safety and environmental chemical risks.
  • Further development and application of in vivo genotoxicity assays are essential for public health protection.